Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma

Hiromitsu Hatakeyama, Haixia Cheng, Pamela Wirth et al. · 2010

Read Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma by Hiromitsu Hatakeyama, Haixia Cheng, Pamela Wirth et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012702.txt.

Description

Hatakeyama, Cheng, Wirth and co-authors traced how head and neck cancers escape a targeted drug. Cetuximab blocks the EGFR growth receptor, yet tumours often learn to resist it over time. Their 2010 study proposed that long blockade makes the cancer raise levels of the receptor's own trigger molecules.

One such trigger, HB-EGF, turned out to be raised by a small RNA called miR-212 falling away. Restoring that balance could revive the drug's power. The chain they outline gives doctors a marker for resistance and a possible way around it.

Catalog record

CREATORHiromitsu Hatakeyama, Haixia Cheng, Pamela Wirth et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012702

Browse the full library · About the Tower of Babel